Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study).
Saved in:
| Title: | Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study). |
|---|---|
| Authors: | Jaïs, Marie1 (AUTHOR), Roblot, Pascal1,2 (AUTHOR), Maillot, François3,4 (AUTHOR), Hamidou, Mohamed5,6 (AUTHOR), Enfrein, Antoine5 (AUTHOR), Lescoat, Alain7,8 (AUTHOR), Puyade, Mathieu1,9 (AUTHOR), Martin, Mickaël1,2,10 (AUTHOR) mickael.martin@univ-poitiers.fr, Perier, Amandine11 (AUTHOR) amandine.perier@ch-niort.fr |
| Source: | Rheumatology International. Nov2024, Vol. 44 Issue 11, p2465-2471. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
